Table 2. Effects table for carfilzomib (study PX‐171‐009).
Table includes treatment‐emergent grade 3 or higher adverse events. Treatment‐emergent adverse events are defined as any adverse event with an onset date between the date of first dose and 30 days after the date of last dose of any study drug. Adverse events were coded using MedDRA version 15.1 and graded using NCI‐CTCAE version 4.0.
Abbreviations: CR, complete response; CRd, carfilzomib with Revlimid (lenalidomide; Celgene, Durham, NC, http://www.celgene.com) with low‐dose dexamethasone; HR, hazard ratio; NE, not estimable; ORR, overall response rate; OS, overall survival; PFS, progression‐free survival; PR, partial response; Rd: Revlimid (lenalidomide) with low‐dose dexamethasone; sCR, stringent complete response; VGPR, very good partial response.